Online first
Original article
Published online: 2024-12-04
The primary study on cardiac troponin T in normal, IUGR, and preterm neonates.
Abstract
Purpose: The study hypothesis was that serum analysis of high-sensitivity troponin T in newborns could be a diagnostic tool to predict the health risks caused by intrauterine growth restriction and preterm birth. Methods: A total of N = 107 newborns were stratified into three groups: 52 healthy (26 male and 26 female), that is, newborns with body weight <10th percentile, born in good condition [Apgar score (APG) 8-10pts] of pregnancy not complicated by diabetes, 21 (10 male and 11 female) with intrauterine growth restriction, that is, weight < 10th centile in centile grids for sex and gestational age of the newborn, and 34 (19 male and 15 female) preterm infants, that is, children born between 22 and 36 weeks from gestation counted from the first day of the last menstrual period. The lowest minimum troponin levels of 0.004 ng/mL defined the preterm group. Results: The healthy group was defined by the highest maximal troponin levels (0.895 ng/mL), while the intrauterine growth restriction group had the lowest maximal troponin level of 0.539 ng/mL. A significant difference was observed between the IUGR and premature groups, P = 0.00413. Conclusions: cTnT levels between IUGR and preterm newborns reflect developmental differences between these two groups that can influence future child development
Keywords: troponin Tneonatesintrauterine growth restrictionpretermdiagnostics
References
- Sharma D, Shastri S, Farahbakhsh N, et al. Intrauterine growth restriction - part 1. J Matern Fetal Neonatal Med. 2016; 29(24): 3977–3987.
- Sharma D, Shastri S, Sharma P. Intrauterine growth restriction: antenatal and postnatal aspects. Clin Med Insights Pediatr. 2016; 10: 67–83.
- Peleg, D., C.M. Kennedy, and S.K. Hunter, Intrauterine growth restriction: identification and management. Am Fam Physician, 1998. 58(2): p 453-60. : 466–7.
- de Bie HMA, Oostrom KJ, Delemarre-van de Waal HA. Brain development, intelligence and cognitive outcome in children born small for gestational age. Horm Res Paediatr. 2010; 73(1): 6–14.
- Saleem T, Sajjad N, Fatima S, et al. Intrauterine growth retardation-small events, big consequences. Ital J Pediatr. 2011; 37: 41.
- Iruretagoyena JI, Gonzalez-Tendero A, Garcia-Canadilla P, et al. Cardiac dysfunction is associated with altered sarcomere ultrastructure in intrauterine growth restriction. Am J Obstet Gynecol. 2014; 210(6): 550.e1–550.e7.
- Corstius HB, Zimanyi MA, Maka N, et al. Effect of intrauterine growth restriction on the number of cardiomyocytes in rat hearts. Pediatr Res. 2005; 57(6): 796–800.
- Wadley, G.D., G.K. McConell, C.A. Goodman, A.L. Siebel, K.T. Westcott, and M.E. Wlodek, Growth restriction in the rat alters expression of metabolic genes during postnatal cardiac development in a sex-specific manner. Physiological Genomics, 2013. 45(3): p. : 99–105.
- Mair J, Puschendorf B, Michel G. Clinical significance of cardiac contractile proteins for the diagnosis of myocardial injury. Adv Clin Chem. 1994; 31: 63–98.
- Al-Hadi, H.A. and K.A. Fox, Cardiac markers in the early diagnosis and management of patients with acute coronary syndrome. Sultan Qaboos Univ Med J, 2009. 9(3): p. : 231–46.
- Rasmussen M, Jin JP. Troponin variants as markers of skeletal muscle health and diseases. Front Physiol. 2021; 12: 747214.
- Saggin L, Gorza L, Ausoni S, et al. Troponin i switching in the developing heart. J Biol Chem. 1989; 264(27): 16299–16302.
- Babuin L, Jaffe AS, Knoll G, et al. Kidney Transplant Working Group of the Canadian Society of Transplantation. Canadian Society of Transplantation consensus guidelines on eligibility for kidney transplantation. CMAJ. 2005; 173(10): 1181–1184.
- Bodor G, Survant L, Voss E, et al. Cardiac troponin T composition in normal and regenerating human skeletal muscle. Clinical Chemistry. 1997; 43(3): 476–484.
- Fonarow GC, Adams KF, Abraham WT, et al. Risk stratification for in-hospital mortality in acutely decompensated heart failure. Classification and regression tree analysis. JAMA. 2005; 293(5): 572–580.
- Abiko M, Inai K, Shimada E, et al. The prognostic value of high sensitivity cardiac troponin T in patients with congenital heart disease. J Cardiol. 2018; 71(4): 389–393.
- Muzyk P, Twerenbold R, Morawiec B, et al. Use of cardiac troponin in the early diagnosis of acute myocardial infarction. Kardiol Pol. 2020; 78(11): 1099–1106.
- Sobczuk K, Janiak K, Draga-Zapora E, et al. Troponin T as a marker of postnatal state of newborn with non-immune hydrops fetalis. Clin Obstet Gynecol Reprod Med. 2017; 3(1).
- Szymankiewicz M, Matuszczak-Wleklak M, Hodgman JE, et al. Usefulness of cardiac troponin T and echocardiography in the diagnosis of hypoxic myocardial injury of full-term neonates. Biol Neonate. 2005; 88(1): 19–23.
- Clerico A, Aimo A, Cantinotti M. High-sensitivity cardiac troponins in pediatric population. Clin Chem Lab Med. 2022; 60(1): 18–32.
- Clark SJ, Newland P, Yoxall CW, et al. Concentrations of cardiac troponin T in neonates with and without respiratory distress. Arch Dis Child Fetal Neonatal Ed. 2004; 89(4): F348–F352.
- Karlén J, Karlsson M, Eliasson H, et al. Cardiac Troponin T in Healthy Full-Term Infants. Pediatr Cardiol. 2019; 40(8): 1645–1654.
- Clark SJ, Newland P, Yoxall CW, et al. Concentrations of cardiac troponin T in neonates with and without respiratory distress. Arch Dis Child Fetal Neonatal Ed. 2004; 89(4): F348–F352.
- Jiang Li, Li Y, Zhang Z, et al. Use of high-sensitivity cardiac troponin I levels for early diagnosis of myocardial injury after neonatal asphyxia. J Int Med Res. 2019; 47(7): 3234–3242.
- Correale M, Nunno L, Ieva R, et al. Troponin in newborns and pediatric patients. Cardiovasc Hematol Agents Med Chem. 2009; 7(4): 270–278.
- Tarkowska A, Furmaga-Jabłońska W. The evaluation of cardiac troponin t in newborns. Biomed Hub. 2017; 2(3): 1–7.
- Trevisanuto D, Lachin M, Zaninotto M, et al. Cardiac troponin T in newborn infants with transient myocardial ischemia. Biol Neonate. 1998; 73(3): 161–165.
- Baum H, Hinze A, Bartels P, et al. Reference values for cardiac troponins T and I in healthy neonates. Clin Biochem. 2004; 37(12): 1079–1082.
- Guo Q, Yang Di, Zhou Y, et al. Establishment of the reference interval for high-sensitivity cardiac troponin T in healthy children of Chongqing Nan'an district. Scand J Clin Lab Invest. 2021; 81(7): 579–584.
- Clark SJ, Newland P, Yoxall CW, et al. Sequential cardiac troponin T following delivery and its relationship with myocardial performance in neonates with respiratory distress syndrome. Eur J Pediatr. 2006; 165(2): 87–93.
- Cohen E, Wong FY, Horne RSC, et al. Intrauterine growth restriction: impact on cardiovascular development and function throughout infancy. Pediatr Res. 2016; 79(6): 821–830.
- Tarkowska A, Furmaga-Jabłońska W. The evaluation of diagnostic role of cardiac troponin T (cTnT) in newborns with heart defects. ScientificWorldJournal. 2012; 2012: 682538.
- Bensley JG, De Matteo R, Harding R, et al. The effects of preterm birth and its antecedents on the cardiovascular system. Acta Obstet Gynecol Scand. 2016; 95(6): 652–663.
- Ciccone MM, Scicchitano P, Zito A, et al. Different functional cardiac characteristics observed in term/preterm neonates by echocardiography and tissue doppler imaging. Early Hum Dev. 2011; 87(8): 555–558.